TY - JOUR
T1 - Quality of Life in Older Adults After Major Cancer Surgery
T2 - The GOSAFE International Study
AU - SIOG Surgical Task Force
AU - ESSO GOSAFE Study Group
AU - Montroni, Isacco
AU - Ugolini, Giampaolo
AU - Saur, Nicole M.
AU - Rostoft, Siri
AU - Spinelli, Antonino
AU - Van Leeuwen, Barbara L.
AU - De Liguori Carino, Nicola
AU - Ghignone, Federico
AU - Jaklitsch, Michael T.
AU - Somasundar, Ponnandai
AU - Garutti, Anna
AU - Zingaretti, Chiara
AU - Foca, Flavia
AU - Vertogen, Bernadette
AU - Nanni, Oriana
AU - Wexner, Steven D.
AU - Audisio, Riccardo A.
AU - Taffurelli, Giovanni
AU - Zattoni, Davide
AU - Tramelli, Paola
AU - Sermonesi, Giacomo
AU - Ercolani, Giorgio
AU - Tauceri, Francesca
AU - Perenze, Barbara
AU - Di Pietrantonio, Daniela
AU - Mirarchi, Mariateresa
AU - Garulli, Gianluca
AU - Alagna, Vincenzo
AU - Lucchi, Andrea
AU - Pirrera, Basilio
AU - Monari, Francesco
AU - Conti, Luigi
AU - Capelli, Patrizio
AU - Romboli, Andrea
AU - Palmieri, Gerardo
AU - Banchini, Filippo
AU - Di Candido, Francesca
AU - Carvello, Michele
AU - Sacchi, Matteo
AU - De Lucia, Francesca
AU - Foppa, Caterina
AU - Marano, Luigi
AU - Spaziani, Alessandro
AU - Castagnoli, Giampaolo
AU - Bartoli, Alberto
AU - Frain, Laura
AU - Cooper, Lisa
AU - Levy, Yochai
AU - Brenner, Baruch
AU - Kashtan, Hanoch
N1 - Publisher Copyright:
© The Author(s) 2022. Published by Oxford University Press.
PY - 2022/7/1
Y1 - 2022/7/1
N2 - Background: Accurate quality of life (QoL) data and functional results after cancer surgery are lacking for older patients. The international, multicenter Geriatric Oncology Surgical Assessment and Functional rEcovery after Surgery (GOSAFE) Study compares QoL before and after surgery and identifies predictors of decline in QoL. Methods: GOSAFE prospectively collected data before and after major elective cancer surgery on older adults (≥70 years). Frailty assessment was performed and postoperative outcomes recorded (30, 90, and 180 days postoperatively) together with QoL data by means of the three-level version of the EuroQol five-dimensional questionnaire (EQ-5D-3L), including 2 components: an index (range ¼ 0-1) generated by 5 domains (mobility, self-care, ability to perform the usual activities, pain or discomfort, anxiety or depression) and a visual analog scale. Results: Data from 26 centers were collected (February 2017-March 2019). Complete data were available for 942/1005 consecutive patients (94.0%): 492 male (52.2%), median age 78 years (range ¼ 70-95 years), and primary tumor was colorectal in 67.8%. A total 61.2% of all surgeries were via a minimally invasive approach. The 30-, 90-, and 180-day mortality was 3.7%, 6.3%, and 9%, respectively. At 30 and 180 days, postoperative morbidity was 39.2% and 52.4%, respectively, and Clavien-Dindo III-IV complications were 13.5% and 18.7%, respectively. The mean EQ-5D-3L index was similar before vs 3 months but improved at 6 months (0.79 vs 0.82; P < .001). Domains showing improvement were pain and anxiety or depression. A Flemish Triage Risk Screening Tool score greater than or equal to 2 (odds ratio [OR] ¼ 1.58, 95% confidence interval [CI] ¼ 1.13 to 2.21, P ¼ .007), palliative surgery (OR ¼ 2.14, 95% CI ¼ 1.01 to 4.52, P ¼ .046), postoperative complications (OR ¼ 1.95, 95% CI ¼ 1.19 to 3.18, P ¼ .007) correlated with worsening QoL. Conclusions: GOSAFE shows that older adults’ preoperative QoL is preserved 3 months after cancer surgery, independent of their age. Frailty screening tools, patient-reported outcomes, and goals-of-care discussions can guide decisions to pursue surgery and direct patients’ expectations.
AB - Background: Accurate quality of life (QoL) data and functional results after cancer surgery are lacking for older patients. The international, multicenter Geriatric Oncology Surgical Assessment and Functional rEcovery after Surgery (GOSAFE) Study compares QoL before and after surgery and identifies predictors of decline in QoL. Methods: GOSAFE prospectively collected data before and after major elective cancer surgery on older adults (≥70 years). Frailty assessment was performed and postoperative outcomes recorded (30, 90, and 180 days postoperatively) together with QoL data by means of the three-level version of the EuroQol five-dimensional questionnaire (EQ-5D-3L), including 2 components: an index (range ¼ 0-1) generated by 5 domains (mobility, self-care, ability to perform the usual activities, pain or discomfort, anxiety or depression) and a visual analog scale. Results: Data from 26 centers were collected (February 2017-March 2019). Complete data were available for 942/1005 consecutive patients (94.0%): 492 male (52.2%), median age 78 years (range ¼ 70-95 years), and primary tumor was colorectal in 67.8%. A total 61.2% of all surgeries were via a minimally invasive approach. The 30-, 90-, and 180-day mortality was 3.7%, 6.3%, and 9%, respectively. At 30 and 180 days, postoperative morbidity was 39.2% and 52.4%, respectively, and Clavien-Dindo III-IV complications were 13.5% and 18.7%, respectively. The mean EQ-5D-3L index was similar before vs 3 months but improved at 6 months (0.79 vs 0.82; P < .001). Domains showing improvement were pain and anxiety or depression. A Flemish Triage Risk Screening Tool score greater than or equal to 2 (odds ratio [OR] ¼ 1.58, 95% confidence interval [CI] ¼ 1.13 to 2.21, P ¼ .007), palliative surgery (OR ¼ 2.14, 95% CI ¼ 1.01 to 4.52, P ¼ .046), postoperative complications (OR ¼ 1.95, 95% CI ¼ 1.19 to 3.18, P ¼ .007) correlated with worsening QoL. Conclusions: GOSAFE shows that older adults’ preoperative QoL is preserved 3 months after cancer surgery, independent of their age. Frailty screening tools, patient-reported outcomes, and goals-of-care discussions can guide decisions to pursue surgery and direct patients’ expectations.
UR - http://www.scopus.com/inward/record.url?scp=85134427114&partnerID=8YFLogxK
U2 - 10.1093/jnci/djac071
DO - 10.1093/jnci/djac071
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 35394037
AN - SCOPUS:85134427114
SN - 0027-8874
VL - 114
SP - 969
EP - 978
JO - Journal of the National Cancer Institute
JF - Journal of the National Cancer Institute
IS - 7
ER -